Terms: = Kidney tumors AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Diagnosis
62 results:
1. Update on Selected High-grade Renal Cell Carcinomas of the kidney: FH-deficient, alk-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract] [Full Text] [Related]
2. alk-rearranged renal cell carcinoma (alk-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract] [Full Text] [Related]
3. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
4. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract] [Full Text] [Related]
5. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
6. What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R; Siadat F; Trpkov K
Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
[TBL] [Abstract] [Full Text] [Related]
7. New insights in the new WHO classification of adult renal tumors.
Hes O; Michalová K; Pivovarčíková K
Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
[TBL] [Abstract] [Full Text] [Related]
8. alk-rearranged renal cell carcinoma with TPM3::alk gene fusion and review of the literature.
Galea LA; Hildebrand MS; Witkowski T; Joy C; McEvoy CR; Hanegbi U; Aga A
Virchows Arch; 2023 Mar; 482(3):625-633. PubMed ID: 36370168
[TBL] [Abstract] [Full Text] [Related]
9. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
10. alk rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report.
Kai K; Tobu S; Kido S; Mikami S; Takeuchi K; Dobashi A; Togashi Y; Noguchi M; Aishima S
Diagn Pathol; 2022 Jun; 17(1):52. PubMed ID: 35718773
[TBL] [Abstract] [Full Text] [Related]
11. alk Translocation in alk-Positive Mesenchymal tumors: Diagnostic and Therapeutic Insights.
Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
[TBL] [Abstract] [Full Text] [Related]
12. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of Cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
13. Renal cell carcinoma in children and adolescents: a retrospective study of a French-Italian series of 93 cases.
Denize T; Massa S; Valent A; Militti L; Bertolotti A; Barisella M; Rioux-Leclercq N; Malouf GG; Spreafico F; Verschuur A; van der Beek J; Tytgat L; van den Heuvel-Eibrink MM; Vujanic G; Collini P; Coulomb A
Histopathology; 2022 May; 80(6):928-945. PubMed ID: 35238063
[TBL] [Abstract] [Full Text] [Related]
14. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
[No Abstract] [Full Text] [Related]
15. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemistry for the diagnosis of renal epithelial neoplasms.
Akgul M; Williamson SR
Semin Diagn Pathol; 2022 Jan; 39(1):1-16. PubMed ID: 34823973
[TBL] [Abstract] [Full Text] [Related]
17. Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments.
Agaimy A; Hartmann A; Trpkov K; Hes O
Semin Diagn Pathol; 2021 Nov; 38(6):152-162. PubMed ID: 34579992
[TBL] [Abstract] [Full Text] [Related]
18. The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients.
Taborelli M; Serraino D; Cimaglia C; Furian L; Biancone L; Busnach G; Todeschini P; Bossini N; Iaria M; Campise MR; Veroux M; Citterio F; Ambrosini A; Cantaluppi V; Mangino M; Pisani F; Tisone G; Fiorentino M; Argiolas D; Caputo F; Piselli P;
Am J Transplant; 2022 Feb; 22(2):588-598. PubMed ID: 34464503
[TBL] [Abstract] [Full Text] [Related]
19. "Collecting duct carcinoma of the kidney: diagnosis and implications for management".
Cabanillas G; Montoya-Cerrillo D; Kryvenko ON; Pal SK; Arias-Stella JA
Urol Oncol; 2022 Dec; 40(12):525-536. PubMed ID: 34116936
[TBL] [Abstract] [Full Text] [Related]
20. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
Barthélémy P; Rioux-Leclercq N; Thibault C; Saldana C; Borchiellini D; Chevreau C; Desmoulins I; Gobert A; Hilgers W; Khalil A; Lemoine N; Schlürmann-Constans F; Négrier S
Cancer Treat Rev; 2021 Jun; 97():102191. PubMed ID: 34015728
[TBL] [Abstract] [Full Text] [Related]
[Next]
